mitomycin has been researched along with Lacrimal Duct Obstruction in 53 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)
| Excerpt | Relevance | Reference |
|---|---|---|
| "2 mg/ml Mitomycin-C solution of was the most effective medication for office probing and syringing in reducing epiphora symptom in nasolacrimal duct obstruction patients." | 9.14 | Probing and syringing with 3% solution of NaCl and/or 0.2 mg/ml mitomycin-C in nasolacrimal duct obstruction patients. ( Choontanom, R, 2010) |
| "Although mitomycin C has no adverse effects when applied to the opening of the nasolacrimal duct, its use after lacrimal probing for the treatment of congenital nasolacrimal duct obstruction does not improve the chance of success." | 7.96 | Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children. ( Akaishi, PM; Cruz, AAV; Dolmetsch, A; Galindo-Ferreiro, A; Galvez-Ruiz, A; Khandekar, R; Schellini, SA, 2020) |
| "To determine the outcome and safety of nonlaser endonasal dacryocystorhinostomy (NLEN-DCR) with the use of adjunctive mitomycin C (MMC) in congenital, traumatic, and primary acquired nasolacrimal duct obstruction in adults." | 7.76 | Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults. ( Dolmetsch, AM, 2010) |
| "A total of 15 eyes of 14 patients diagnosed with primary acquired nasolacrimal duct obstruction were assigned randomly to either a mitomycin C group or a control group." | 5.08 | Dacryocystorhinostomy with intraoperative mitomycin C. ( Chen, MS; Hou, PK; Kao, SC; Liao, CL; Tseng, JH, 1997) |
| "This is a retrospective non-randomized study of surgical outcome in patients of primary acquired nasolacrimal duct obstruction who underwent an Arrugas bone trephine assisted flapless dacryocystorhinostomy with Circumosteal - Mitomycin C (group A) versus those who underwent conventional external dacryocystorhinostomy (group B) in a teaching hospital in North India." | 4.02 | Arrugas Bone Trephine Assisted Flapless Dacryocystorhinostomy with Circumosteal - Mitomycin C Versus External Dacryocystorhinostomy: A Hospital Based Comparative Study. ( Ambastha, A; Bhaskar, G; Mohan, N; Shree, S; Sinha, S, 2021) |
| "The objective of the study was to compare the success rate of transcanalicular laser dacryocystorhinostomy (TCL-DCR) with or without the use of adjunctive mitomycin C (MMC) in cases with primary nasolacrimal duct obstruction (NLDO)." | 3.85 | Efficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy. ( Balci, O; Demirci, G; Ozsutcu, M; Tanriverdi, C, 2017) |
| "The aim of the study was to assess practice patterns on the use of intraoperative Mitomycin-C (MMC) and lacrimal stents (intubation) in dacryocystorhinostomy (DCR) for nasolacrimal duct obstruction (NLDO) among oculoplastic surgeons in India." | 3.83 | Indian Survey on Practice Patterns of Lacrimal and Eyelid Disorders (iSUPPLE) Report 2: Mitomycin-C and Lacrimal Stents in Dacryocystorhinostomy. ( Agarwal, A; Kamal, S; Nair, AG, 2016) |
| "To determine the outcome and safety of nonlaser endonasal dacryocystorhinostomy (NLEN-DCR) with the use of adjunctive mitomycin C (MMC) in congenital, traumatic, and primary acquired nasolacrimal duct obstruction in adults." | 3.76 | Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults. ( Dolmetsch, AM, 2010) |
| "To evaluate the safety and efficacy of mitomycin-C irrigation after balloon dacryocystoplasty in the treatment of epiphora caused by obstruction of the lacrimal system." | 3.74 | Efficacy of mitomycin-C irrigation after balloon dacryocystoplasty. ( Choi, EK; Kim, JH; Kim, KR; Lee, YJ; Shin, JH; Song, HY; Yang, ZQ, 2007) |
| "Mitomycin C in appropriate dose minimizes postoperative fibrosis and granulations, thereby maintaining a bigger postoperative ostium throughout the postoperative observation period." | 3.73 | Effect of mitomycin C on ostium in dacryocystorhinostomy. ( Barua, CK; Bhattacharjee, H; Bhattacharjee, K; Bhuyan, SK; Deka, A; Khaund, G, 2006) |
| "Mitomycin-C use may lead to lacrimal apparatus fibrosis and symptomatic epiphora when inciting a toxoallergic reaction." | 3.72 | Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. ( Billing, K; Karagiannis, A; Selva, D, 2003) |
| "Mitomycin C does not increase the success rate of revision endoscopic DCR." | 2.77 | Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial. ( Elsherif, HS; Gamea, AM; Ragab, SM; Shehata, EM; Younes, A, 2012) |
| "Epiphora due to nasolacrimal duct obstruction is a common condition worsening one's quality of life." | 1.56 | Endoscopic dacryocystorhinostomy with circumostial mitomycin C injection, simultaneous limited septoplasty and the use of tissue glue. ( Nowak, I; Nowak, R, 2020) |
| "Persistent congenital nasolacrimal duct obstruction refractory to earlier interventions of probing or intubation was the most common indication for the surgery noted in 57% (77/135)." | 1.51 | Outcomes in paediatric external dacryocystorhinostomy: a single-centre experience. ( Ali, MJ; Dave, TV; Ezeanosike, E; Naik, MN, 2019) |
| " EE-DCR with adjunctive MMC and TA is a safe and successful procedure for the treatment of NLDO." | 1.43 | Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy. ( Cheng, AC; Li, EY; Sze, AM; Wong, AC; Yuen, HK, 2016) |
| "Past history of acute dacryocystitis was noted in 35." | 1.43 | Endoscopic ultrasonic dacryocystorhinostomy: clinical profile and outcomes. ( Ali, MJ; Chisty, N; Kamal, S; Naik, MN; Singh, M, 2016) |
| "Mitomycin C (MMC) acts as a potent fibroblastic inhibitor, and topical application of MMC is effective in preventing scar formation." | 1.34 | Efficacy of mitomycin C irrigation after removal of an occluded nasolacrimal stent. ( Choi, EK; Kim, JH; Kim, KR; Lee, YJ; Shin, JH; Song, HY, 2007) |
| "Mitomycin C appears to be a safe and effective adjunct therapy in correcting punctal stenosis." | 1.31 | Mitomycin C as adjunct therapy in correcting punctal stenosis. ( Awwad, ST; Hamush, NG; Ma'luf, RN; Noureddin, BN, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (9.43) | 18.2507 |
| 2000's | 17 (32.08) | 29.6817 |
| 2010's | 20 (37.74) | 24.3611 |
| 2020's | 11 (20.75) | 2.80 |
| Authors | Studies |
|---|---|
| Tara, S | 1 |
| Panickar, N | 1 |
| Puthur, D | 1 |
| Chen, R | 1 |
| Liu, S | 1 |
| Jiang, A | 1 |
| Wumaier, A | 1 |
| Yang, Y | 1 |
| Yu, X | 1 |
| Meng, Z | 1 |
| Mao, Y | 1 |
| Liang, X | 1 |
| Bhaskar, G | 1 |
| Ambastha, A | 1 |
| Mohan, N | 1 |
| Sinha, S | 1 |
| Shree, S | 1 |
| Atkova, EL | 1 |
| Fedorov, AA | 1 |
| Root, AO | 1 |
| Krakhovetsky, NN | 1 |
| Yartsev, VD | 1 |
| Wu, A | 1 |
| Curragh, DS | 1 |
| Morrow, R | 1 |
| Selva, D | 4 |
| Davis, G | 1 |
| Phelps, PO | 1 |
| Abariga, SA | 1 |
| Cowling, BJ | 1 |
| Marcet, MM | 1 |
| Vinciguerra, A | 1 |
| Nonis, A | 1 |
| Giordano Resti, A | 1 |
| Bussi, M | 1 |
| Trimarchi, M | 1 |
| Galindo-Ferreiro, A | 1 |
| Khandekar, R | 1 |
| Akaishi, PM | 1 |
| Cruz, AAV | 1 |
| Galvez-Ruiz, A | 1 |
| Dolmetsch, A | 1 |
| Schellini, SA | 1 |
| Nowak, R | 1 |
| Nowak, I | 1 |
| Yim, M | 1 |
| Wormald, PJ | 1 |
| Doucet, M | 1 |
| Gill, A | 1 |
| Kingdom, T | 1 |
| Orlandi, R | 1 |
| Crum, A | 1 |
| Marx, D | 1 |
| Alt, J | 1 |
| Khadka, S | 1 |
| Joshi, P | 1 |
| Basnet, PS | 1 |
| Pradhan, C | 1 |
| Abd El Ghafar, AS | 1 |
| El-Kannishy, AM | 1 |
| Elwan, MM | 1 |
| Sabry, D | 1 |
| Kishk, HM | 1 |
| Elhefney, EM | 1 |
| Dave, TV | 1 |
| Ezeanosike, E | 1 |
| Naik, MN | 2 |
| Ali, MJ | 5 |
| Paulsen, F | 1 |
| Cheng, SM | 1 |
| Feng, YF | 2 |
| Xu, L | 1 |
| Li, Y | 1 |
| Huang, JH | 2 |
| Xue, K | 1 |
| Mellington, FE | 1 |
| Norris, JH | 1 |
| Qian, Z | 1 |
| Zhang, Y | 1 |
| Fan, X | 1 |
| Li, EY | 1 |
| Cheng, AC | 1 |
| Wong, AC | 1 |
| Sze, AM | 1 |
| Yuen, HK | 1 |
| Nair, AG | 3 |
| Singh, M | 1 |
| Chisty, N | 1 |
| Kamal, S | 3 |
| Do, JR | 1 |
| Lee, H | 1 |
| Baek, S | 1 |
| Lee, TS | 1 |
| Chang, M | 1 |
| Ozsutcu, M | 2 |
| Balci, O | 1 |
| Tanriverdi, C | 1 |
| Demirci, G | 1 |
| Agarwal, A | 1 |
| Kashkouli, MB | 1 |
| Parvaresh, MM | 1 |
| Mirzajani, H | 1 |
| Astaraki, A | 1 |
| Falavarjani, KG | 1 |
| Ahadian, A | 1 |
| Rathore, PK | 1 |
| Kumari Sodhi, P | 1 |
| Pandey, RM | 1 |
| Dolmetsch, AM | 1 |
| Choontanom, R | 1 |
| Ragab, SM | 1 |
| Elsherif, HS | 1 |
| Shehata, EM | 1 |
| Younes, A | 1 |
| Gamea, AM | 1 |
| Görgülü, O | 1 |
| Ozdemir, S | 1 |
| Görgülü, FF | 1 |
| Altin, A | 1 |
| Selçuk, T | 1 |
| Akbaş, Y | 1 |
| Sinha, MK | 1 |
| Bajaj, MS | 1 |
| Pushker, N | 1 |
| Ghose, S | 1 |
| Chandra, M | 1 |
| Yu, JG | 1 |
| Shi, JL | 1 |
| Sun, YL | 1 |
| Zhao, YE | 1 |
| Dogan, R | 1 |
| Meric, A | 1 |
| Yenigun, A | 1 |
| Ma'luf, RN | 1 |
| Hamush, NG | 1 |
| Awwad, ST | 1 |
| Noureddin, BN | 1 |
| Liu, D | 1 |
| Bosley, TM | 1 |
| Billing, K | 1 |
| Karagiannis, A | 1 |
| Keerl, R | 1 |
| Weber, R | 1 |
| Goldstein, DA | 1 |
| Tessler, HH | 1 |
| Boboridis, K | 1 |
| Ziakas, N | 1 |
| Georgiadis, N | 1 |
| Kopp, ED | 1 |
| Seregard, S | 1 |
| Khong, JJ | 1 |
| Muecke, J | 1 |
| Leibovitch, I | 1 |
| Deka, A | 1 |
| Bhattacharjee, K | 1 |
| Bhuyan, SK | 1 |
| Barua, CK | 1 |
| Bhattacharjee, H | 1 |
| Khaund, G | 1 |
| Kim, KR | 2 |
| Song, HY | 2 |
| Shin, JH | 2 |
| Kim, JH | 2 |
| Choi, EK | 2 |
| Lee, YJ | 2 |
| Yang, ZQ | 1 |
| Nemet, AY | 1 |
| Wilcsek, G | 1 |
| Francis, IC | 1 |
| Kao, SC | 2 |
| Liao, CL | 1 |
| Tseng, JH | 1 |
| Chen, MS | 1 |
| Hou, PK | 1 |
| Ugurbas, SH | 2 |
| Zilelioglu, G | 1 |
| Sargon, MF | 1 |
| Anadolu, Y | 1 |
| Akiner, M | 1 |
| Aktürk, T | 1 |
| Zilelioğiu, G | 1 |
| Yeatts, RP | 1 |
| Neves, RB | 1 |
| Rosser, PM | 1 |
| Camara, JG | 1 |
| Bengzon, AU | 1 |
| Henson, RD | 1 |
| Tsai, CC | 1 |
| Kau, HC | 1 |
| Hsu, WM | 1 |
| Liu, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis[NCT01772277] | 400 participants (Anticipated) | Observational | 2012-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for mitomycin and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.
Topics: Antimetabolites; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacryocystorhinostomy; Female; F | 2020 |
Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.
Topics: Alkylating Agents; Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Mitomycin; S | 2020 |
Adjunctive techniques to dacryocystorhinostomy: an evidence-based review with recommendations.
Topics: Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Mitomycin; Nasal Septum; Nasola | 2021 |
Ultrastructure of the lacrimal drainage system in health and disease: A major review.
Topics: Bacteria; Biofilms; Cicatrix; Constriction, Pathologic; Dacryocystorhinostomy; Fibrinolytic Agents; | 2019 |
Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis.
Topics: Antibiotics, Antineoplastic; Dacryocystorhinostomy; Databases, Bibliographic; Endoscopy; Female; Hum | 2013 |
Meta-analysis of the adjunctive use of mitomycin C in primary and revision, external and endonasal dacryocystorhinostomy.
Topics: Alkylating Agents; Chemotherapy, Adjuvant; Dacryocystorhinostomy; Humans; Lacrimal Duct Obstruction; | 2014 |
Clinical outcomes of dacryocystorhinostomy with or without intraoperative use of mitomycin C: a systematic review and meta-analysis.
Topics: Cicatrix; Dacryocystitis; Dacryocystorhinostomy; Drug Administration Schedule; Humans; Lacrimal Duct | 2014 |
Mitomycin-C in dacryocystorhinostomy: From experimentation to implementation and the road ahead: A review.
Topics: Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Mitomycin; Nucleic Acid Synthes | 2015 |
A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Dacryocystorhinostomy; Databases, Factual; Fema | 2012 |
[Dacryocystorhinostomy - state of the art, indications, results].
Topics: Dacryocystorhinostomy; Endoscopy; Follow-Up Studies; Humans; Lacrimal Duct Obstruction; Laser Therap | 2004 |
There is no use crying over spilt tears: the surgical management of primary acquired nasolacrimal duct obstruction.
Topics: Catheterization; Dacryocystorhinostomy; Humans; Lacrimal Duct Obstruction; Mitomycin; Nucleic Acid S | 1999 |
7 trials available for mitomycin and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
Reestablishing Lacrimal Drainage by Canaliculorhinostomy after Dacryocystectomy: A Viable Option in Symptomatic Patients.
Topics: Dacryocystorhinostomy; Female; Humans; Lacerations; Lacrimal Duct Obstruction; Male; Mitomycin; Naso | 2022 |
Probing and syringing with 3% solution of NaCl and/or 0.2 mg/ml mitomycin-C in nasolacrimal duct obstruction patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Female; Humans; Lacrimal Duct Obstruction; Male; Middle Ag | 2010 |
Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial.
Topics: Adult; Combined Modality Therapy; Dacryocystorhinostomy; Endoscopy; Female; Humans; Lacrimal Duct Ob | 2012 |
Efficacy of probing with mitomycin-C in adults with primary acquired nasolacrimal duct obstruction.
Topics: Adult; Alkylating Agents; Dacryocystorhinostomy; Female; Follow-Up Studies; Humans; Lacrimal Duct Ob | 2013 |
Diode laser-assisted endoscopic dacryocystorhinostomy: a comparison of three different combinations of adjunctive procedures.
Topics: Aged; Analysis of Variance; Antibiotics, Antineoplastic; Combined Modality Therapy; Dacryocystorhino | 2013 |
Silicone nasolacrimal intubation with mitomycin-C: a prospective, randomized, double-masked study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Child, Preschool; Combined Modality The | 2003 |
Dacryocystorhinostomy with intraoperative mitomycin C.
Topics: Chemotherapy, Adjuvant; Dacryocystorhinostomy; Follow-Up Studies; Humans; Intraoperative Care; Lacri | 1997 |
35 other studies available for mitomycin and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
A simple and efficient technique for suturing and knotting during endoscopic dacryocystorhinostomy.
Topics: Dacryocystorhinostomy; Endoscopy; Female; Humans; Lacrimal Duct Obstruction; Male; Middle Aged; Mito | 2023 |
Arrugas Bone Trephine Assisted Flapless Dacryocystorhinostomy with Circumosteal - Mitomycin C Versus External Dacryocystorhinostomy: A Hospital Based Comparative Study.
Topics: Dacryocystorhinostomy; Endoscopy; Hospitals; Humans; Lacrimal Duct Obstruction; Mitomycin; Nasolacri | 2021 |
Morphological features of regenerative processes after dacryocystorinostomy with the use of mitomycin C.
Topics: Collagen; Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Mitomycin | 2023 |
Nasolacrimal duct obstruction secondary to lacrimal sac involvement by sebaceous carcinoma.
Topics: Adenocarcinoma, Sebaceous; Antibiotics, Antineoplastic; Dacryocystorhinostomy; Eye Neoplasms; Female | 2020 |
Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.
Topics: Child, Preschool; Dacryocystorhinostomy; Humans; Lacrimal Duct Obstruction; Mitomycin; Nasolacrimal | 2020 |
Endoscopic dacryocystorhinostomy with circumostial mitomycin C injection, simultaneous limited septoplasty and the use of tissue glue.
Topics: Aged; Alkylating Agents; Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Male; | 2020 |
Outcomes of Conventional External Dacryocystorhinostomy with and without Mitomycin C: Experience from Eastern Nepal.
Topics: Alkylating Agents; Dacryocystorhinostomy; Endoscopy; Humans; Lacrimal Duct Obstruction; Mitomycin; N | 2020 |
Perforated punctal plugs with adjuvant use of mitomycin-C in management of acquired external punctal stenosis grades 0 and 1.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Equipment Design; Eyel | 2017 |
Outcomes in paediatric external dacryocystorhinostomy: a single-centre experience.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Dacryocystorhinostomy; Female; Humans; Infan | 2019 |
Safety and efficacy of adjunctive intranasal mitomycin C and triamcinolone in endonasal endoscopic dacryocystorhinostomy.
Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Alkylating Agents; Anti-Inflammatory Age | 2016 |
Endoscopic ultrasonic dacryocystorhinostomy: clinical profile and outcomes.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Dacryocystitis; Dacryocysto | 2016 |
Efficacy of postoperative mitomycin-C eye drops on the clinical outcome in endoscopic dacryocystorhinostomy.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Alkylating Agents; Dacryocystorhinostomy; E | 2016 |
Efficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy.
Topics: Adult; Chemotherapy, Adjuvant; Dacryocystorhinostomy; Female; Follow-Up Studies; Humans; Lacrimal Du | 2017 |
Outcomes of endoscopic dacryocystorhinostomy: Experience of a fellowship trainee at a tertiary care center.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Child; Child, Preschool; Dacryocystorhinostomy; Educatio | 2016 |
Indian Survey on Practice Patterns of Lacrimal and Eyelid Disorders (iSUPPLE) Report 2: Mitomycin-C and Lacrimal Stents in Dacryocystorhinostomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dacryocystorhinostomy; Endoscopy; Femal | 2016 |
Intraoperative mitomycin C use during filtration surgery and lacrimal drainage system obstruction.
Topics: Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Dacryocystorhinostomy; Female | 2009 |
Topical mitomycin C as a postoperative adjunct to endonasal dacryocystorhinostomy in patients with anatomical endonasal variants.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Dacryo | 2009 |
Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Dacryocyst | 2010 |
Adjunctive use of mitomycin C in endoscopic revision dacryocystorhinostomy.
Topics: Adolescent; Adult; Alkylating Agents; Child; Child, Preschool; Dacryocystorhinostomy; Endoscopy; Fem | 2012 |
Mitomycin C as adjunct therapy in correcting punctal stenosis.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Eyelid Diseases; Female; Humans; Lacrim | 2002 |
Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Corneal Diseases; Female; Fibrosis; Humans; La | 2003 |
Re: mitomycin-induced punctal stenosis.
Topics: Antibiotics, Antineoplastic; Humans; Lacrimal Duct Obstruction; Mitomycin; Nasolacrimal Duct | 2004 |
Nasolacrimal intubation with mitomycin C.
Topics: Antibiotics, Antineoplastic; Dacryocystorhinostomy; Humans; Intubation; Lacrimal Duct Obstruction; M | 2004 |
Epiphora as a side effect of topical mitomycin C.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctival N | 2004 |
Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
Topics: Adenocarcinoma, Sebaceous; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2006 |
Mitomycin C in dacryocystorhinostomy.
Topics: Alkylating Agents; Cell Proliferation; Combined Modality Therapy; Dacryocystorhinostomy; Fibrosis; H | 2006 |
Effect of mitomycin C on ostium in dacryocystorhinostomy.
Topics: Adolescent; Adult; Alkylating Agents; Cell Proliferation; Child; Child, Preschool; Combined Modality | 2006 |
Efficacy of mitomycin C irrigation after removal of an occluded nasolacrimal stent.
Topics: Adult; Aged; Dacryocystorhinostomy; Device Removal; Female; Follow-Up Studies; Humans; Kaplan-Meier | 2007 |
Efficacy of mitomycin-C irrigation after balloon dacryocystoplasty.
Topics: Adult; Aged; Aged, 80 and over; Catheterization; Female; Follow-Up Studies; Humans; Kaplan-Meier Est | 2007 |
Endoscopic dacryocystorhinostomy with adjunctive mitomycin C for canalicular obstruction.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Dacryocystorhinostomy; Endoscopy; Female; H | 2007 |
Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy.
Topics: Antibiotics, Antineoplastic; Dacryocystorhinostomy; Endoscopy; Follow-Up Studies; Humans; Lacrimal A | 1997 |
Dacryocystorhinostomy with intraoperative mitomycin C.
Topics: Antibiotics, Antineoplastic; Dacryocystorhinostomy; Humans; Intraoperative Care; Lacrimal Duct Obstr | 1998 |
Use of mitomycin C in repeat dacryocystorhinostomy.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Dacryocystorhinostomy; Female; Humans; Lacrima | 1999 |
The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Dacryocystorhinostomy; Endoscopy; Female; Hu | 2000 |
Efficacy of probing the nasolacrimal duct with adjunctive Mitomycin-C for epiphora in adults.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Dacryocystorhinostomy; | 2002 |